Search results
Results From The WOW.Com Content Network
Sanofi offers a range of trivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype & type B virus. Please see Important Safety Information or Prescribing Information.
Fluzone High-Dose is the first and only influenza vaccine proven superior to a standard-dose flu vaccine in adults aged 65+ and has more than 12 years of real-world evidence (2009-2010 to 2019-2020, and 2021-2022) in the prevention of influenza outcomes including influenza hospitalization.
Sanofi Pasteur Inc. Get the CPT code, CVX code, and NDC code of Fluzone High-Dose (Influenza Vaccine), Flublok (Influenza Vaccine), and Fluzone (Influenza Vaccine) for this flu season. Please see Important Safety Information or Prescribing Information.
Sanofi is committed to supporting your immunization efforts and helping to inform your patients. Here, you’ll find a collection of helpful brochures and resources that provide information about our influenza vaccines.
Fluzone, a trivalent influenza vaccine, has a 3-strain defense system used for the prevention of influenza caused by influenza A subtype and type B virus in patients aged 6 months and older.
INDICATIONS. Fluzone, Flublok, and Fluzone High-Dose are vaccines indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. Fluzone is approved for use in persons 6 months of age and older.
Flublok is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and influenza type B virus contained in the vaccine. Flublok is approved for use in persons 18 years of age and older.
(INFLUENZA VACCINE) FOR ADULTS 65+ COMPARED WITH A STANDARD-DOSE FLU VACCINE* WHAT IS FLUZONE® HIGH-DOSE QUADRIVALENT (INFLUENZA VACCINE)? FLUZONE® HIGH-DOSE QUADRIVALENT is a vaccine that helps protect against influenza illness (flu). FLUZONE® HIGH-DOSE QUADRIVALENT vaccine is for people 65 years of age and older.
Flublok Quadrivalent is a vaccine indicated for immunization against disease caused by influenza A and B strains contained in the vaccine. Flublok Quadrivalent is given to people 18 years of age and older.
INDICATIONS. Fluzone, Flublok, and Fluzone High-Dose are vaccines indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. Fluzone is approved for use in persons 6 months of age and older.